IT1255390B - Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione - Google Patents

Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione

Info

Publication number
IT1255390B
IT1255390B ITMI922233A ITMI922233A IT1255390B IT 1255390 B IT1255390 B IT 1255390B IT MI922233 A ITMI922233 A IT MI922233A IT MI922233 A ITMI922233 A IT MI922233A IT 1255390 B IT1255390 B IT 1255390B
Authority
IT
Italy
Prior art keywords
pharmaceutical products
procedure
preparation
treat cancer
cancer diseases
Prior art date
Application number
ITMI922233A
Other languages
English (en)
Inventor
Gabor Somlyai
Original Assignee
Gabor Somlyai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gabor Somlyai filed Critical Gabor Somlyai
Publication of ITMI922233A0 publication Critical patent/ITMI922233A0/it
Publication of ITMI922233A1 publication Critical patent/ITMI922233A1/it
Application granted granted Critical
Publication of IT1255390B publication Critical patent/IT1255390B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invenzione riguarda prodotti per curare malattie tumorali, comprendenti come agente attivo acqua o soluzioni acquose adatte per il consumo umano, aventi un contenuto di deuterio da 0,1 a 110 parti per milione, facoltativamente assieme con veicoli e/o ausiliari, sotto forma di prodotti farmaceutici o soluzioni medicinali. Inoltre l'invenzione riguarda un procedimento per preparare questi prodotti.
ITMI922233A 1991-10-31 1992-09-28 Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione IT1255390B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases

Publications (3)

Publication Number Publication Date
ITMI922233A0 ITMI922233A0 (it) 1992-09-28
ITMI922233A1 ITMI922233A1 (it) 1994-03-28
IT1255390B true IT1255390B (it) 1995-10-31

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922233A IT1255390B (it) 1991-10-31 1992-09-28 Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione

Country Status (22)

Country Link
US (1) US5855921A (it)
JP (1) JP3569916B2 (it)
KR (1) KR100253874B1 (it)
CN (1) CN1045162C (it)
AT (1) AT402692B (it)
BE (1) BE1006186A3 (it)
CA (1) CA2122612C (it)
CH (1) CH685282A5 (it)
CZ (1) CZ282379B6 (it)
DE (1) DE4232465B4 (it)
DK (1) DK170832B1 (it)
ES (1) ES2077530B1 (it)
FI (1) FI114010B (it)
FR (1) FR2683148B1 (it)
GB (1) GB2276086B (it)
HU (1) HU208084B (it)
IT (1) IT1255390B (it)
LU (1) LU88175A1 (it)
NL (1) NL194664C (it)
NO (1) NO307031B1 (it)
SE (1) SE513624C2 (it)
WO (1) WO1993008794A1 (it)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0738114T3 (da) * 1994-01-06 2001-11-26 Hyd Kutato Fejleszto Ktf Næringsmiddelprodukt til forebyggelse af udvikling af sygdomme og fremgangsmåder til fremstilling af dette
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
ATE412906T1 (de) * 2002-02-12 2008-11-15 Univ California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
US20060094057A1 (en) 2002-07-30 2006-05-04 Maro K. Hellerstein Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
JP4610337B2 (ja) * 2002-09-13 2011-01-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗アテローム発生の指標としてのｉｎｖｉｖｏでの逆コレステロール輸送速度の測定方法
WO2004042360A2 (en) 2002-11-04 2004-05-21 The Regents Of The Univeristy Of California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
BRPI0520020A2 (pt) * 2005-02-08 2009-04-14 Woodford Associates Ltd bebidas alccoólicas enriquecidas com 1h2 16o
RS20070331A (sr) * 2005-02-08 2009-03-25 Woodford Asociates Ltd., Bezalkoholno piće obogaćeno sa 1h216o
WO2006096082A1 (en) * 2005-03-05 2006-09-14 Sergey Pavlovich Soloviev Cosmetic composition enriched with 1h216o
EP1855699B1 (en) * 2005-03-11 2012-08-15 Sergey Pavlovich Soloviev Light pharmaceutical water and therapeutic compositions and methods thereof
CN101146448A (zh) * 2005-03-11 2008-03-19 维达咨询有限公司 用于消毒无生命表面的组合物
US20080103092A1 (en) * 2005-03-11 2008-05-01 Pomytkin Igor A Methods for Intradermal, Transdermal or Transmucosal Delivery of Biologically Active Substances
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
RU2287324C1 (ru) * 2005-04-29 2006-11-20 Тамази Владимирович Баззаев Мазь для лечения ожоговых ран
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
EA014535B1 (ru) * 2005-12-12 2010-12-30 Тимантти Аб Способ подавления аппетита и снижения объема поглощения пищи
US20080292719A1 (en) * 2005-12-12 2008-11-27 Igor Anatolievich Pomytkin Method of Treating Metabolic Syndrome
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE102009017966A1 (de) 2009-04-21 2010-11-04 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
JP6110846B2 (ja) * 2011-05-27 2017-04-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｃ型肝炎ウイルス阻害剤としての重水素が導入されたトリペプチド
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
WO2013036885A1 (en) 2011-09-08 2013-03-14 The Regents Of The University Of California Metabolic flux measurement, imaging and microscopy
ES2668678T3 (es) 2011-12-07 2018-05-21 Glaxosmithkline Llc Procedimiento de determinación de la masa muscular esquelética corporal total
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
JP2017526638A (ja) * 2014-06-30 2017-09-14 ミトコンドリアル サブストレート インベンション リミテッドＭｉｔｏｃｈｏｎｄｒｉａｌ Ｓｕｂｓｔｒａｔｅ Ｉｎｖｅｎｔｉｏｎ Ｌｉｍｉｔｅｄ 認知機能向上のための栄養素溶液
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
AU2017329108B2 (en) * 2016-09-21 2022-07-07 Botanical Water Technologies Ip Ltd Isotopic compositions
CA3087342A1 (en) * 2018-01-02 2019-07-11 Botanical Water Technologies Ip Ltd Isotopic enriched water
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用
CN120078803A (zh) * 2025-03-05 2025-06-03 江苏睿景生物技术有限公司 低氘水对肿瘤细胞生长抑制的作用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
EP0335918A1 (en) * 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
FI114010B (fi) 2004-07-30
NL194664C (nl) 2002-11-04
DE4232465B4 (de) 2008-11-06
FR2683148B1 (fr) 1994-09-09
CH685282A5 (de) 1995-05-31
KR100253874B1 (ko) 2000-04-15
HU208084B (en) 1993-08-30
SE9401406L (sv) 1994-06-07
LU88175A1 (fr) 1993-03-15
GB2276086B (en) 1995-09-27
WO1993008794A1 (en) 1993-05-13
BE1006186A3 (fr) 1994-06-07
SE9401406D0 (sv) 1994-04-25
JPH08501275A (ja) 1996-02-13
CZ282379B6 (cs) 1997-07-16
FI941979A0 (fi) 1994-04-29
ITMI922233A0 (it) 1992-09-28
US5855921A (en) 1999-01-05
AT402692B (de) 1997-07-25
NL194664B (nl) 2002-07-01
FI941979L (fi) 1994-06-29
NO307031B1 (no) 2000-01-31
ES2077530A1 (es) 1995-11-16
DK170832B1 (da) 1996-02-05
CA2122612C (en) 2003-02-04
GB2276086A (en) 1994-09-21
CZ102094A3 (en) 1994-12-15
GB9408654D0 (en) 1994-07-20
CA2122612A1 (en) 1993-05-13
NO941590D0 (it) 1994-04-29
ITMI922233A1 (it) 1994-03-28
FR2683148A1 (fr) 1993-05-07
KR930007461A (ko) 1993-05-20
NL9220026A (nl) 1994-09-01
CN1045162C (zh) 1999-09-22
DE4232465A1 (de) 1993-05-06
JP3569916B2 (ja) 2004-09-29
NO941590L (it) 1994-06-23
SE513624C2 (sv) 2000-10-09
CN1071836A (zh) 1993-05-12
ES2077530B1 (es) 1996-07-01
HU913437D0 (en) 1992-01-28
ATA902992A (de) 1996-12-15

Similar Documents

Publication Publication Date Title
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
MY113059A (en) Controlled-release dosage forms of azithromycin
MY124853A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives.
BRPI0412426A (pt) uso da zd6474 ou de um sal farmaceuticamente aceitável da mesma e de um agente antitumoral de platina, composição farmacêutica, kit, e método para a produção de um efeito antiangiogênico e/ou redutor de permeabilidade vascular em um animal de sangue quente
PL340096A1 (en) Methods of treating hypercoagulability states or hypoproteinaemia in respect to c protein
CA2223776A1 (en) Method of treatment for lung diseases using antisense oligonucleotides
PT1098643E (pt) Fenilacetilglutamina fenilacetilisoglutamina e/ou fenilacetato para o tratamento de doencas neoplasicas
BG103647A (en) Cisplatina containing microgranules
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
MX9302038A (es) Metodo para el tratamiento del cancer por una terapia conjunta con derivados de 2-halometilideno y un agente antineoplasico especifico de fase m o fase s.
RU2000132310A (ru) Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
KR930000114A (ko) 지방산을 이용한 치료
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
MXPA02009603A (es) Terapias de dosis divididas con actividad de deterioro vascular.
AU1601499A (en) Citicoline to treat motor neuron diseases and demyelinating diseases
MX9603241A (es) Productos farmaceuticos para curar enfermedades tumorales y procedimiento para su preparacion.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
Danilenko et al. Prolonged pharmacologic sleep in the complex treatment of patients with severe forms of alcoholic delirium
UA23301A (uk) Спосіб приготуваhhя ембіхіhу для іh'єкцій
钟红文 et al. COMPARATIVE OBSERVATION ON TREATMENT OF PSYCHOSIS WITH ELECTRODE AND ELECTRO-ACUPUNCTURE CONTROLLED BY PROCESSORS
Zheng et al. Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations
RU98105539A (ru) Способ лечения псориаза

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970930